Member login

Not a Member?

Site logo

Therapeutic advances in coeliac disease

RC 2017 3


Daniel Leffler, MD, MS currently serves as the Director of Research at the Celiac Center at Beth Israel Deaconess Medical Center and is an Associate Professor of Medicine at Harvard Medical School. Dr Leffler currently serves as a Medical Director in the Gastrointestinal Therapeutic Area at Takeda Pharmaceuticals as well as continuing to care for patients with coeliac disease and other gastrointestinal disorders and he participates in clinical and translational research in coeliac disease. 


Over the past 20 years, celiac disease has evolved from a condition felt to be rare with little if any unmet medical need, to a disease known to be common and for which current therapy is suboptimal for many patients. In this talk Dr Leffler reviews the reasons why novel therapeutic options are now felt to be valuable, a variety of agents currently under investigation and the methodology and rational for evaluating safety and efficacy of new treatments for coeliac disease.

Print page Add to My Scrapbook
Show Footer Menu